Backed by some of the world’s most advanced medical research, we are committed to excellence and innovation.
Research is vital to transform IVF success rates, because current success rates world-wide are significantly lower than for other elective treatment such as cataract surgery or hip replacement which are generally over 95% successful. The likely success rate for many patients, even at the very best clinics, can be below 10% for poor prognosis patients.
Our aim is to achieve the best success rates in Europe. Our approach to date has been largely based on learning from the latest techniques, equipment, diagnostics and drug protocols being used by clinics worldwide.
Achieving the fundamental improvements that we are aiming for requires research. It is for this reason that we had three staff at the European Society for Human Reproduction annual conference where the latest research is presented.
Our Lead Nurse attended a conference in Italy that was held to consider the latest research on optimising Luteinising Hormone (LH). An optimal level of LH is critical for egg and therefore embryo quality.
Two of our senior clinicians have reviewed practice at one of Europe’s leading clinics in Spain and our team have been working with a leading clinic in Germany and leads in the UK.
One of our lead clinicians attended the world’s largest conference on fertility medicine in the United States, where the very latest research world-wide was presented.
Recent studies and research
We are currently focusing on the following areas, using audits and analyses to optimise treatment and participating with research partners on novel areas aimed at achieving a ‘step change’ in success rates.
Team
